A Phase 1, Open-Label, Randomized, Adaptive, Cross-Over Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects with Advanced or Metastatic Solid Tumors (Abbott Laboratories #M12-468).
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2012
At a glance
- Drugs Linifanib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 29 Feb 2012 Actual number of patient (14) added as reported by ClinicalTrials.gov.
- 29 Feb 2012 Actual end date (1 Jan 2012) added as reported by ClinicalTrials.gov.
- 29 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.